AstraZeneca Partners with Revna Biosciences to Enhance Epidermal Growth Factor Receptor (EGFR) Biomarker Testing in Ghana

This partnership goes beyond diagnostics and research, extending towards targeted therapies for patients tailored to their unique genetic makeup. AstraZeneca, a global biopharmaceutical company is in collaboration with Revna Biosciences